retina 2024 web page banner

2024 SPEAKERS

Sulagna Bhattacharya

Nanoscope Therapeutics

Margaret Chang, MD

Retinal Consultants of Sacramento

Anna Chen

Frazier Life Sciences

Emmett T. Cunningham Jr., MD, PhD, MPH

Eyconis / HealthQuest Capital Management

Anupam Dalal, MD

Acuta Capital Partners

Tim de Gavre

Sandoz

Dilsher Dhoot, MD

California Retina Consultants

Pravin U. Dugel, MD

Ocular Therapeutix
Peter Francis MD PhD

Peter Francis, MD, PhD

Ray Therapeutics

Alan J. Franklin, MD, PhD

ForwardVue Pharma

Andrew Gitkin

Leerink Partners
Mark-Humayun

Mark S. Humayun, MD, PhD

University of Southern California Roski Eye Institute
Baruch Kupperman

Baruch Kuppermann, MD, PhD

University of California

Samarendra Mohanty, PhD

Nanoscope Therapeutics
Andrew Moshfeghi, MD, MBA

Andrew A. Moshfeghi, MD, MBA

USC Roski Eye Institute - Keck School of Medicine - University of Southern California
Firas M. Rahhal, MD

Firas Rahhal, MD

ExSight Ventures & Retina Vitreous Associates Medical Group
Steven Schwartz

Steven Schwartz, MD

Jules Stein Eye Institute, UCLA

Michael Singer, MD

UT Health San Antonio
Rishi Singh MD

Rishi P. Singh, MD, FASRS

Vice President/Chief Medical Officer of Martin Hospitals Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine

Jay Stewart, MD

University of California, San Francisco

Ivo Stoilov, MD

Genentech

Caroline Stout

EcoR1 Capital

Cameron Taylor

BofA Securities | Life Sciences

Jonathan Weyne

Regeneron
Charles Wykoff, MD

Charles Wykoff, MD, PhD

Retina Consultants of Texas, Retina Consultants of America, Houston Methodist Hospital & Blanton Eye Institute